Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0110
-0.0020 (-15.38%)
Aug 26, 2026, 4:10 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 797.05 thousand as of August 26, 2026. Its market cap has decreased by -91.84% in one year.
Market Cap
797.05K
Enterprise Value
-1.71M
Revenue
9.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 797.05K, a decrease of -99.18%. That is a compound annual growth rate of -57.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 797.05K | -90.30% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 11.24M |
| Vectus Biosystems | 9.22M |
| Invex Therapeutics | 9.02M |
| Bio-Gene Technology | 8.32M |
| Zelira Therapeutics | 5.95M |
| Biotron | 5.40M |
| Tissue Repair | 5.32M |
| Acrux | 5.31M |